Correction: Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virus

Correction: Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virus

Bibliographic Details
Main Authors:	Uksha Saini, Brentley Q. Smith, Kalpana Deepa Priya Dorayappan, Ji Young Yoo, G. Larry Maxwell, Balveen Kaur, Ikuo Konishi, David O’Malley, David E. Cohn, Karuppaiyah Selvendiran
Format:	Article
Language:	English
Published:	BMC 2023-02-01
Series:	Journal of Ovarian Research
Online Access:	https://doi.org/10.1186/s13048-023-01111-7

Similar Items

Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virus
by: Uksha Saini, et al.
Published: (2022-12-01)

High Glucose-Mediated STAT3 Activation in Endometrial Cancer Is Inhibited by Metformin: Therapeutic Implications for Endometrial Cancer.
by: John J Wallbillich, et al.
Published: (2017-01-01)

ISG15 mediates the function of extracellular vesicles in promoting ovarian cancer progression and metastasis
by: Kalpana Deepa Priya Dorayappan, et al.
Published: (2024-02-01)

Expression of CCL19 from Oncolytic Vaccinia Enhances Immunotherapeutic Potential while Maintaining Oncolytic Activity
by: Jun Li, et al.
Published: (2012-12-01)

1098 Oncolytic HSV blocking tumor-intrinsic PKR sensitizes glioblastoma to immunotherapy
by: Balveen Kaur, et al.
Published: (2023-11-01)

Replication and Spread of Oncolytic Herpes Simplex Virus in Solid Tumors
by: Bangxing Hong, et al.
Published: (2022-01-01)

The current status of oncolytic viral therapy for head and neck cancer
by: Matthew O. Old, et al.
Published: (2016-06-01)

Upregulation of TMEM45A Promoted the Progression of Clear Cell Renal Cell Carcinoma in vitro
by: Jiang H, et al.
Published: (2021-12-01)

Deciphering the Multifaceted Relationship between Oncolytic Viruses and Natural Killer Cells
by: Christopher A. Alvarez-Breckenridge, et al.
Published: (2012-01-01)

Oncolytic peptides DTT-205 and DTT-304 induce complete regression and protective immune response in experimental murine colorectal cancer
by: Karianne Giller Fleten, et al.
Published: (2021-03-01)

STAT3 activation promotes oncolytic HSV1 replication in glioma cells.
by: Kazuo Okemoto, et al.
Published: (2013-01-01)

Overexpression of PLCG2 and TMEM38A inhibit tumor progression in clear cell renal cell carcinoma
by: Yiqiao Zhao, et al.
Published: (2025-01-01)

Enhanced IL-12 transgene expression improves oncolytic viroimmunotherapy
by: Yeaseul Kim, et al.
Published: (2024-06-01)

oHSV-P10 reduces glioma stem cell enrichment after oncolytic HSV therapy
by: Upasana Sahu, et al.
Published: (2023-06-01)

Cover_205
Published: (2021-07-01)

Cryo-EM structures of human TMEM120A and TMEM120B
by: Meng Ke, et al.
Published: (2021-08-01)

The complex relationship between integrins and oncolytic herpes Simplex Virus 1 in high-grade glioma therapeutics
by: Kimberly Ann Rivera-Caraballo, et al.
Published: (2022-09-01)

Combinatorial immunotherapy with anti-ROR1 CAR NK cells and an IL-21 secreting oncolytic virus against neuroblastoma
by: Yaya Chu, et al.
Published: (2025-03-01)

Combination lenvatinib plus pembrolizumab in the treatment of ovarian clear cell carcinoma: A case series
by: Corinne A. Calo, et al.
Published: (2023-04-01)

Tmem176B and Tmem176A are associated with the immature state of dendritic cells.
by: Condamine, T, et al.
Published: (2010)

PKR induces TGF-β and limits oncolytic immune therapy
by: Balveen Kaur, et al.
Published: (2023-02-01)

Generation of human TMEM16F-specific affibodies using purified TMEM16F
by: Eunyoung Kim, et al.
Published: (2024-01-01)

Paneth Cell Secretion in vivo Requires Expression of Tmem16a and Tmem16f
by: Rainer Schreiber, et al.
Published: (2022-01-01)

Development of the Olfactory Epithelium and Nasal Glands in TMEM16A-/- and TMEM16A+/+ Mice.
by: Devendra Kumar Maurya, et al.
Published: (2015-01-01)

Overexpression and crystallization of 205Y lipase from Bacillus sphaericus 205Y
by: Hamooni, Sayyedeh Hoda
Published: (2017)

Cell cycle regulation by the Wee1 Inhibitor PD0166285, Pyrido [2,3-d] pyimidine, in the B16 mouse melanoma cell line
by: Sakamoto Masaharu, et al.
Published: (2006-12-01)

Tmem119-EGFP and Tmem119-CreERT2 Transgenic Mice for Labeling and Manipulating Microglia
by: Kaiser, Tobias, et al.
Published: (2020)

TMEM16 and OSCA/TMEM63 proteins share a conserved potential to permeate ions and phospholipids
by: Augustus J Lowry, et al.
Published: (2024-11-01)

SARS-CoV-2 replicates and displays oncolytic properties in clear cell and papillary renal cell carcinoma.
by: Oi Kuan Choong, et al.
Published: (2023-01-01)

TMEM Proteins in Cancer: A Review
by: Kathleen Schmit, et al.
Published: (2018-12-01)

Ipk 205- Bahan Plastik
by: PPJJ, Pusat Pengajian Jarak Jauh
Published: (2003)

Oncolytic Viruses
by: Nanhai G. Chen, et al.
Published: (2012-01-01)

Oncolytic virotherapy
by: Daniel Cervantes-García;, et al.
Published: (2008-01-01)

PTEN expression by an oncolytic herpesvirus directs T-cell mediated tumor clearance
by: Luke Russell, et al.
Published: (2018-11-01)

Characterising the rhomboid-like protein TMEM115
by: Shen, X
Published: (2017)

Comprehensive analysis of TMEM9 in human tumors
by: Xuezhong Zhang, et al.
Published: (2025-03-01)

The effect of Tmem135 overexpression on the mouse heart.
by: Sarah Aileen Lewis, et al.
Published: (2018-01-01)

Contrasting effects of phosphatidylinositol 4,5-bisphosphate (PIP2 ) on cloned TMEM16A and TMEM16B channels
by: Ta, C, et al.
Published: (2017)

Oncolytic Viral Therapy in Osteosarcoma
by: Thomas Karadimas, et al.
Published: (2024-07-01)

BMT 205 - IMMUNOLOGY APRIL 08.
by: PPSKJ, Pusat Pengajian Sains Kajihayat
Published: (2008)